Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion type Assertion NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_head.
- NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion description "[We compared the effect of serum from (a) 26 Alzheimer's disease (AD) patients and 22 age-matched non-demented controls (CO) with apolipoprotein E 4/4, 3/3 or 3/2 phenotypes, and (b) 17 normal young (aged 15-41 years) and 21 normal elderly (aged 64-83 years) people on in vitro aggregation of synthetic amyloid beta-protein (A beta) 1-40 by Thioflavin T fluorescence spectroscopy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_provenance.
- NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion evidence source_evidence_literature NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_provenance.
- NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion SIO_000772 9562306 NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_provenance.
- NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion wasDerivedFrom befree-2016 NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_provenance.
- NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_assertion wasGeneratedBy ECO_0000203 NP1393824.RAcbBuB0leDdGyj1QbUp85vL40pVwS3yw8Llynr4v8zNE130_provenance.